UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 178

Sortiert nach

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

BMC medicine, 2008-07, Vol.6 (1), p.19-19, Article 19

2008

Link zum Volltext

Verfügbarkeit prüfen

False-positive screening results in the European randomized study of screening for prostate cancer

European journal of cancer (1990), 2011-12, Vol.47 (18), p.2698-2705

2011

Link zum Volltext

Verfügbarkeit prüfen

Stopping screening, when and how?

Translational andrology and urology, 2018-02, Vol.7 (1), p.46-53

Hugosson, Jonas

2018

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Clinical chemistry (Baltimore, Md.), 2006-02, Vol.52 (2), p.235-239

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality

Journal of medical screening, 2012-09, Vol.19 (3), p.133-140

2012

Link zum Volltext

Verfügbarkeit prüfen

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Annals of internal medicine, 2017-10, Vol.167 (7), p.449

2017

Link zum Volltext

Verfügbarkeit prüfen

Association of surgeon and hospital volume with short-term outcomes after robotassisted radical prostatectomy : Nationwide, population-based study

PloS one, 2021-06, Vol.16 (6 June 2021)

2021

Link zum Volltext

Verfügbarkeit prüfen

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.04.024

European urology, 2016

2016

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial” [Eur Urol (2022)]

European urology, 2023-03, Vol.83 (3), p.e88-e88

2023

Link zum Volltext

Verfügbarkeit prüfen

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11

European urology, 2013-11, Vol.64 (5), p.711-712

2013

Link zum Volltext

Verfügbarkeit prüfen

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11: Should Men Older Than Age 70 Be Recommended Against Screening?

European urology, 2013-11, Vol.64 (5), p.711-712

2013

Link zum Volltext

Verfügbarkeit prüfen

1731 HOW SCREENING DOES AFFECT ERECTILE FUNCTION AND URINARY CONTINENCE FOLLOWING RADICAL PROSTATECTOMY - RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)

The Journal of urology, 2010, Vol.183 (4), p.e669-e669

2010

Link zum Volltext

Verfügbarkeit prüfen

The quality of radical prostatectomies must be ensured

Läkartidningen, 2017-07, Vol.114

2017

Link zum Volltext

Verfügbarkeit prüfen

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

BJU international, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

The dilemmas of prostate cancer screening

Medical journal of Australia, 2013-11, Vol.199 (9), p.583-584

2013

Link zum Volltext

Verfügbarkeit prüfen

The impact of design and performance in PSA screening: differences between ERSPC centers

European urology, 2019-04, Vol.76 (3), p.276-279

2019

Link zum Volltext

Verfügbarkeit prüfen

A comparison of side-effects and quality-of-life in patients operated on for prostate cancer with and without salvage radiation therapy

Scandinavian journal of urology, 2020-09, Vol.54 (5), p.393-400

2020

Link zum Volltext

Verfügbarkeit prüfen

MP46-01 DEVELOPMENT OF PROSTATE CANCER SCREENING NOMOGRAMS FOR PREDICTING 15-YEAR RISK OF PROSTATE CANCER DIAGNOSIS AND PROSTATE CANCER MORTALITY, WITH OTHER-CAUSE MORTALITY AS COMPETING EVENT

The Journal of urology, 2018-04, Vol.199 (4), p.e606-e606

2018

Link zum Volltext

Verfügbarkeit prüfen

MP46-02 PROSTATE CANCER SCREENING NOMOGRAM PREDICTING 15-YEAR RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER, DEVELOPED USING COMPETING RISK ANALYSIS

The Journal of urology, 2018-04, Vol.199 (4), p.e606-e606

2018

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer - diagnostics and screening

Läkartidningen, 2024-04, Vol.121

2024

Link zum Volltext

Verfügbarkeit prüfen

Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy

European urology oncology, 2024-06, Vol.7 (3), p.553-562

2024

Link zum Volltext

Verfügbarkeit prüfen

PD35-04 COULD DIFFERENCES IN TREATMENT BETWEEN TRIAL ARMS EXPLAIN THE REDUCTION IN PROSTATE CANCER MORTALITY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER?

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Link zum Volltext

Verfügbarkeit prüfen

Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.87-87

2019

Link zum Volltext

Verfügbarkeit prüfen

Thromboembolic Complications in 3,544 Patients Undergoing Radical Prostatectomy with or without Lymph Node Dissection

The Journal of urology, 2015, Vol.193 (1), p.117-125

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 178

Suche als RSS-Feed

Aktive Filter

ThemaUrology And Nephrology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(51)
European Urology
(18)
Scandinavian Journal Of Urology And Nephrology
(18)
Bju International
(9)
World Journal Of Urology
(6)
Cancer
(5)
Journal Of Medical Screening
(5)
Läkartidningen
(5)
Urology
(5)
Clinical Chemistry
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

False-positive screening results in the European randomized study of screening for prostate cancer

Stopping screening, when and how?

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Association of surgeon and hospital volume with short-term outcomes after robotassisted radical prostatectomy : Nationwide, population-based study

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.04.024

Corrigendum to “Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial” [Eur Urol (2022)]

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11: Should Men Older Than Age 70 Be Recommended Against Screening?

1731 HOW SCREENING DOES AFFECT ERECTILE FUNCTION AND URINARY CONTINENCE FOLLOWING RADICAL PROSTATECTOMY - RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)

The quality of radical prostatectomies must be ensured

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

The dilemmas of prostate cancer screening

The impact of design and performance in PSA screening: differences between ERSPC centers

A comparison of side-effects and quality-of-life in patients operated on for prostate cancer with and without salvage radiation therapy

MP46-01 DEVELOPMENT OF PROSTATE CANCER SCREENING NOMOGRAMS FOR PREDICTING 15-YEAR RISK OF PROSTATE CANCER DIAGNOSIS AND PROSTATE CANCER MORTALITY, WITH OTHER-CAUSE MORTALITY AS COMPETING EVENT

MP46-02 PROSTATE CANCER SCREENING NOMOGRAM PREDICTING 15-YEAR RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER, DEVELOPED USING COMPETING RISK ANALYSIS

Prostate cancer - diagnostics and screening

Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy

PD35-04 COULD DIFFERENCES IN TREATMENT BETWEEN TRIAL ARMS EXPLAIN THE REDUCTION IN PROSTATE CANCER MORTALITY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER?

Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making

The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials

Thromboembolic Complications in 3,544 Patients Undergoing Radical Prostatectomy with or without Lymph Node Dissection

Aktive Filter

Suchergebnisse filtern